RAM
DFTX

Reflection Asset Management’s Definium Therapeutics DFTX Stock Holding History

Reflection Asset Management’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$898 Buy
+66
New +$817 ﹤0.01% 491

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Reflection Asset Management's DFTX Position: Q4 2025 in Review

Reflection Asset Management opened a new position in Definium Therapeutics (DFTX) in Q4 2025: 66 shares worth $898. The stake represents ﹤0.01% of the portfolio and ranks #491 among its holdings.

208 funds tracked by Wall St. Rank hold DFTX as of Q4 2025.

  • Reflection Asset Management held 66 shares of Definium Therapeutics worth $898 as of Q4 2025.
  • Definium Therapeutics was a new Reflection Asset Management position in Q4 2025.
  • Definium Therapeutics made up ﹤0.01% of Reflection Asset Management's portfolio in Q4 2025, its #491 holding.
  • 208 funds tracked by Wall St. Rank held Definium Therapeutics as of Q4 2025.

Based on Reflection Asset Management's 13F filing for Q4 2025, filed 2 Mar 2026.